chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FEVER, CHILLS-SHAKING, SORE ARM, DIARRHEA, ACHING ALL OVER ESPECIALLY CHEST AND HEAD, SHARP PAIN RIGHT EAR AND IN LEFT JAW, LACK OF APPETITE, BED RIDDEN 2 DAYS, LARYNGITIS, WEEPING EYES, DIFFICULTY SLEEPING
had some pain in his arm and now pain has gone away; weakness; he has been feeling fatigue and tiredness in general for 3 days; dizziness; malaise in his whole body; feels his feet are cold; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "diabetic" (unspecified if ongoing); "COVID-19", start date: Dec2020, stop date: Dec2020, notes: contracted the Covid 19 infection in DEC 2020. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "had some pain in his arm and now pain has gone away"; ASTHENIA (non-serious), outcome "unknown", described as "weakness"; FATIGUE (non-serious), outcome "unknown", described as "he has been feeling fatigue and tiredness in general for 3 days"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; MALAISE (non-serious), outcome "unknown", described as "malaise in his whole body"; PERIPHERAL COLDNESS (non-serious), outcome "unknown", described as "feels his feet are cold". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information : Patient wants to know if the side effects that he is presenting are reported with the COVID-19 vaccine, he received the first dose on a Pharmacy, he is a diabetic patient, the day of the administration he presented pain in his arm that eventually went away (after 3 days), since 3 days ago until now the patient has presented weakness, fatigue and tiredness, dizziness y general body malaise similar to when he was infected with the COVID-19 virus (he had the infection in December), additionally he also developed cold feet, he is currently taking Tylenol. He also mentioned that he feels like he is "drugged with medications". Referred to his physician for treatment recommendation.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
arm hurt a little; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Covid 19 vaccine with an associated reaction of pain in extremity.   On 9th December 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     Linked case(s) involving the same patient:  US2022066333   Additional Information: GSK Receipt Date: 27-JUN-2022 Reporter's Comments: The patient self-reported this case. The patient received 1st dose of Shingrix and had no reaction other than her arm hurt a little more compared to the Covid 19 vaccine. The patient gave permission to contact her primary care doctor. Additional Supportive Information: For tolerance of 2nd dose refer case US2022066333, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022066333:Same reporter
is case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 56-year-old female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. In April 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. In April 2018, 12 hrs after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced pain in arm, headache and fatigue. On an unknown date, the patient experienced hair loss and incomplete course of vaccination. On an unknown date, the outcome of the pain in arm, headache and fatigue were recovered/resolved and the outcome of the hair loss and incomplete course of vaccination were unknown. It was unknown if the reporter considered the pain in arm, headache, fatigue and hair loss to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 55 or 56 years. The concomitant product includes vitamins unspecified. The patient experienced headache, sore arm and fatigue which lasted for about 2 to 3 days. The patient also reported that she noticed some hair loss, as evidenced by strands in her comb. The patient was scheduled to receive 2nd dose on 29th November 2018 and has past her 6 months indication time frame. Till the time of reporting, the patient did not receive 2nd dose of SHINGRIX, which led to incomplete course of vaccination. The patient did not wish to provide demographics or participate in a safety report. The patient did not consent to follow-up.
My symptom began a five month period before my injury. I was feeling like poking - niddle all over my body.
breakout with shingles; This case was reported by a consumer via (Shingrix) interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a dose of Shingrix vaccine and experienced Shingles. The patient enquired if a person could experience breakout with shingles after 1st dose or not. Follow-up would not be possible as no contact details available,.
Acute onset lower extremity weakness 30Apr10, with diagnosis of, rhabdomyolysis, right leg deep vein thrombosis, and possible GUILLAIN BARRE SYNDROME. Required renal dialysis and is currently in a rehabilitation hospital.
She got her 4th vaccine, it was a slight pinch. She didn't feel anything.  Her daughter took them out for dinner and when she came home she started to feel queasy.  She went to the bathroom and she totally unloaded had diarrhea and violent vomiting for about 20-25 minutes, which in turn hurt her ribs.  She went to bed and did not have any vomiting, but has not eaten or drank anything due to her side hurting.   About 2:30 she took a couple of sips of water and was able to hold that down.  She is leery of drinking anything right now.    She did not have any reactions to any of the other vaccines that she had other than a little sore spot at the injection site.
experienced symptoms and potential positive self-home test several days ago and he called his doctor who prescribed Paxlovid; experienced symptoms and potential positive self-home test several days ago and he called his doctor who prescribed Paxlovid; This is a spontaneous report received from contactable Consumer. The reporter is the patient. An 82-year-old male patient received BNT162b2 (BNT162B2), on 19Jan2021 as dose 1, single (Lot number: EL1283, Expiration Date: Apr2021), in left arm, on 10Feb2021 as dose 2, single (Lot number: EM9810, Expiration Date: Jun2021) and on 23Sep2021 as dose 3 (booster), single (Lot number: FE3592, Expiration Date: Nov2021) at the age of 81 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 04Jun2022 as dose 4(booster), single (Lot number: 037422B), in left arm for covid-19 immunisation. The patient's relevant medical history included: "latent asthma" (ongoing), the only comorbidity he has other than age is latent asthma condition for which he has Albuterol inhaler and he only uses it 2-3 times a year and it is not a big deal and was diagnosed with asthma about 10 years ago. Concomitant medications included: ALBUTEROL [SALBUTAMOL]; ELIQUIS, start date: 2020, he only has the Eliquis lot 1882638 and SN number and NDC of 0003-0894-21 and expiry date Aug2024; ATORVASTATIN [ATORVASTATIN CALCIUM]. Patient has not had as much as a runny nose or sore throat since he was first given the covid vaccines until this occurred and was not sick with anything the entire course of when he started with the covid vaccines in 2021 and they worked like a charm and thought he was impervious and then was shocked with these symptoms and he had not had a runny nose or had that in all this time.  Had no side effects and had zero side effects from all the covid vaccines. The patient did not have additional Vaccines Administered on Same Date of the Pfizer Suspect. The patient did not have any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. 2nd booster covid vaccine of Moderna on 04Jun2022 and looked like it was handwritten on his patient card for the lot 037422B and the 4 in the lot number might actually be the letter A and it was more like an A. Patient went in for the 1st PCR test to see if he was ok as he had been at a picnic with a group of people that had covid the week before so he thought he was exposed to them and better get tested and it was a negative PCR test on 21Jul2022 at 11:30am. He experienced symptoms and potential positive self-home test several days ago and he called his doctor who prescribed Paxlovid for him and picked it up on 24Jul2022 and started taking it that evening with the first dose. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) potential positive, notes: potential positive self home test; (21Jul2022) negative, notes: at 11:30am. Therapeutic measures were taken as a result of drug ineffective, covid-19. Outcome of the events was unknown.
Fever, arthralgias, weakness, vertigo yielding nausea and vomiting.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (This vaccine was given 4 days past the beyond use date of 23-Jun-22) and NO ADVERSE EVENT (No adverse event) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059A22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (This vaccine was given 4 days past the beyond use date of 23-Jun-22). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (This vaccine was given 4 days past the beyond use date of 23-Jun-22) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (This vaccine was given 4 days past the beyond use date of 23-Jun-22). No concomitant drug information was provided. Beyond use date of the product was reported as  23-Jun-2022. It was unknown if the patient was ever diagnosed with or tested COVID-19 positive. It was also unknown if there was any acute illness at the time of vaccination or nay chronic or long standing health conditions of the patient.  Reporter further reported that as per Moderna, the product was still active and patient need not to be re-vaccinated. No treatment drug information was provided. This case was linked to MOD-2022-599989 (Patient Link).
p/vax pt exp dizziness; unsteady gait; h/a; 8/28/98 seen MD; mom states all rpt nl so far; Dx vertigo; 9/13 still some dizziness; unsteady gait
A report was received from a health care professional on 6OCT2003 concerning a 63 year old male vaccinee who inadvertently expired Fluvirin vaccine on 30SEPT2003. On 30SEPT2003, the vaccinee inadvertently received 2002-2003 Fluvirin vaccine. No adverse effect was reported. There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200300760.
Dizziness; Headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIZZINESS (Dizziness) and HEADACHE (Headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced DIZZINESS (Dizziness). April 2021, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. In April 2021, DIZZINESS (Dizziness) and HEADACHE (Headache) had resolved.            Concomitant product information was not provided.  Reporter called on behalf of a neighbor. After receiving the first dose of the vaccine, the patient experienced headaches and dizziness intermittently beginning on an unknown date and resolved in approximately one week.   This case was linked to MOD-2021-101544 (Patient Link).
Information has been received from a physician concerning a female who was vaccinated with a third dose of Gardasil vaccine. Subsequently, the patient experienced extreme pain that lasted for 18 days. Additional information has been requested.
pt recv 2 doses of vax & 25APR96 lab eval revealed a varicella IgG titer of less than 0.86 (not immune);
Uncontrollable coughing, severe ear pain, nausea and vomiting, severe chills
Muscle soreness most of day 1  Slight nausea throughout day 1  Had to take ibuprofen to relieve the muscle soreness
Increase red, swell, pain left arm erythema left lateral axillary node rx with antibiotics.
his brother developed a rash basically like hives across his stomach, chest, and back; Itching; spots that hurts; his brother developed a rash basically like hives across his stomach, chest, and back; This is a spontaneous report from a contactable consumer. A 71-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 05Mar2021 (at the age of 71-years) as dose 1, single for covid-19 immunisation. The patient medical history included melanoma was first diagnosed when he had it in 2015, and then it recurred in his lung last year in July or May of 2020, when they diagnosed it. He says it was removed Jul2020, allergy and allergic to Benzedrine. The patient concomitant medications were not reported. On 09Mar2021, the patient experienced rash, itching. Reporter says he was calling for his brother. He says that his brother got the Pfizer COVID-19 vaccine, he had the first dose this past Friday. He says that Monday afternoon, almost literally 72 hours later, and with no new medications and no changes, his brother developed a rash basically like hives across his stomach, chest, and back. He says his brother said today he sees spots on his arms also. He says the only thing his brother had different was the shot, but nothing happened for about 3 days. He says that his brother said that the itching started yesterday, with spots that hurt, and he would like to know if this was something they had seen before with the vaccine. Reporter says that his brother has not had any new medications in several weeks, though there was a medication that was increased 3 weeks ago, there was nothing new since then, and he hasn't changed diet or anything. Reporter did not provide further details about the medication that was increased. His brother received immunotherapy, 6 treatments. He says after his brother started having the immunotherapy it affected his adrenal gland, so they stopped treatment since then. No further details provided about his brother's immunotherapy. Reporter says that his brother has an appointment to see his dermatologist next Monday about the rash, which is as soon as they could get it in, and he sees the dermatologist regularly because of the melanoma. Reporter says his brother used some topical hydrocortisone on it, and said Monday it had no effect, and yesterday the rash was still there but it doesn't hurt anymore, it seems better. He says for the hydrocortisone cream, his brother immediately put that on after he got the rash on Monday and it had no effect, and yesterday and today the spots are still here, but his brother says that they don't hurt or itch anymore. He says he thinks the rash being better is not from treatment with the cream, since it didn't help immediately. Unspecified hydrocortisone cream UPC/LOT/EXP: Unknown. The outcome of the events was not recovered.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
tired; had no energy; the opposite arm hurt from injection; lazy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 10Feb2021 08:35 (Lot number: EN6201) at the age of 69 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "allergies" (unspecified if ongoing); "compromised immune status" (unspecified if ongoing); "respiratory illness" (unspecified if ongoing); "genetic/chromosomal abnormalities" (unspecified if ongoing); "endocrine abnormalities" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "heart palpitation" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "tired"; LAZINESS (non-serious) with onset 10Feb2021 12:00, outcome "unknown", described as "lazy"; ASTHENIA (non-serious), outcome "unknown", described as "had no energy"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "the opposite arm hurt from injection".  Additional Information: The date of first injection was on 10Feb2021, at 08:35 am. She felt tired and lazy. They got home and had lunch and she was feeling lazy, so she laid on floor and fell asleep for a few hours. It continued for a couple of days and then she was total 4-5 days, was still feeling lazy and had no energy. Nothing hurt. She then stated that the opposite arm hurt from injection. She got injection in left arm and her right arm was sore. She got shot on left arm both times. Both have improved. Her arm was fine after that.  No follow-up attempts are possible. No further information is expected.
migraine with shooting pains in her head; Sleepiness; Excruciating pain; Neck hurt with pain like when she had shringles; first dose had a local reaction arm was hard, hot, and painful; chills; Knee hurt so bad it locked up; first dose had a local reaction arm was hard, hot, and painful; first dose had a local reaction arm was hard, hot, and painful; Back hurt so bad she  can't move; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (first dose had a local reaction arm was hard, hot, and painful), VACCINATION SITE OEDEMA (first dose had a local reaction arm was hard, hot, and painful), VACCINATION SITE PAIN (first dose had a local reaction arm was hard, hot, and painful), MIGRAINE (migraine with shooting pains in her head) and SOMNOLENCE (Sleepiness) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013LZOA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jan-2020, the patient experienced BACK PAIN (Back hurt so bad she  can't move). On 30-Dec-2020, the patient experienced VACCINATION SITE ERYTHEMA (first dose had a local reaction arm was hard, hot, and painful), VACCINATION SITE OEDEMA (first dose had a local reaction arm was hard, hot, and painful), VACCINATION SITE PAIN (first dose had a local reaction arm was hard, hot, and painful), MIGRAINE (migraine with shooting pains in her head), SOMNOLENCE (Sleepiness), CHILLS (chills), NECK PAIN (Neck hurt with pain like when she had shringles) and PAIN (Excruciating pain). 30-Dec-2020, the patient experienced ARTHRALGIA (Knee hurt so bad it locked up). On 02-Jan-2021, SOMNOLENCE (Sleepiness) and CHILLS (chills) outcome was unknown. On 04-Jan-2021, VACCINATION SITE ERYTHEMA (first dose had a local reaction arm was hard, hot, and painful), VACCINATION SITE OEDEMA (first dose had a local reaction arm was hard, hot, and painful) and VACCINATION SITE PAIN (first dose had a local reaction arm was hard, hot, and painful) outcome was unknown. On 07-Jan-2021, BACK PAIN (Back hurt so bad she  can't move), NECK PAIN (Neck hurt with pain like when she had shringles), ARTHRALGIA (Knee hurt so bad it locked up) and PAIN (Excruciating pain) outcome was unknown. On 31-Mar-2021, MIGRAINE (migraine with shooting pains in her head) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 with the events was considered as not applicable. No concomitant Medication was reported by reporter. No Treatment Medication was reported by reporter.   This case was linked to MOD-2021-114639 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Received followup document included No New Information.
I developed flulike symptoms. I had headaches, sinus drainage, had low grade temperature, high as 102 degrees and felt bad body aches. My symptoms lasted seven days.  I still have some long term symptoms today.  My long term symptoms are shortness of breath and fatigue.
Increase of blood pressure over 150/90 after 1st dose went to Dr added new medication. Had second dose blood pressure increased over 200/100 HR over 115 for 2 days. Went to hospital spent 2 days there before got it under control - hypertensive urgency
Information has been received from a 67 year old female (also reported as 57), with a history of nausea on DEMEROL and gastrointestinal bleeding on MOTRIN, and an unspecified hypersensitivity to PROCARDIA, who on 02-OCT-2007 was vaccinated with a first dose of ZOSTAVAX  (Oka/Merck) (Lot # 658208/0886U) 0.65 mL administered subcutaneously into the right upper outer arm. There was no illness at the time of vaccination. Concomitant therapy included PREVACID, ALLERGRA, "allergy shots" (unspecified), FEMHRT, and estradiol. On 03-OCT-2007, "early", the patient reported developing a reaction at the injection site abut 2.5" in diameter, that was red, warm, which at 22:30 became "painful". The patient sought medical attention. The physician reported that on 04 OCT 2007 there was local, painful, erythematous swelling noted over deltoid area. The patient was treated with elevation, ice, acetaminophen and cephalexin (for cellulitis). Symptoms gradually resolved. On approximately 14 OCT 2007 the patient was considered recovered. No labs or diagnostic studies were performed. This is one of several reports from the same source. No further information is expected.